CXRNvsETF 2ETF Comparison
VS
ETF 2
Choose a second ETF to run a side-by-side ETF comparison with CXRN, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
CXRN performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/23/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | CXRN ETF 2 | -25.87%– | -13.71%– | -16.62%– | -17.43%– | n/a– | n/a– |
| Flows | CXRN ETF 2 | -– | -$2M– | +$2M– | +$2M– | -– | -– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | CXRN ETF 2 | +46.81%– | +40.47%– | n/a– | n/a– |
| Max drawdown | CXRN ETF 2 | -30.44%– | -31.71%– | n/a– | n/a– |
| Max drawdown duration | CXRN ETF 2 | 52d– | 113d– | n/a– | n/a– |
Trading data
CXRN | ETF 2 | |
Last sale 10/26/2026 at 1:30 PM | $15.74 | – |
| Previous close 10/23/2026 | $15.86 | – |
| Consolidated volume 10/23/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Replication data will be available soon
Advertisement
Main metrics
Last update 10/26/2026 at 1:30 PM
Live
Closed
CXRN | ETF 2 | |
|---|---|---|
| Last price | $15.74 | – |
| 1D performance | -0.79% | – |
| AuM | $2.38 M | – |
| E/R | 1.49% | – |
Characteristics
CXRN | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | Teucrium | – |
| Benchmark | Corn | – |
| N° of holdings | - | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 12, 2024 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
CXRN
Data will be available soon
ETF 2
Sectors
CXRN
Data will be available soon
ETF 2
Advertisement
Diversification
CXRN
Data will be available soon
ETF 2
–
Top 15 holdings
Data as of January 1, 1970
CXRN
Data will be available soon
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
